AfricaRegulatory
African Pharmaceutical Regulatory Intelligence
🇳🇬
Candesartan Cilexetil in Nigeria
4 products registered with NAFDAC — 4 active
| Brand / Product | Reg. No. | Holder | Status | Expires |
|---|---|---|---|---|
| Advant Tablet 8 mg** Tablet | A4-9123 | Getz Pharma Nigeria Limited | active | 24 May 2028 |
| Advant Tablet 16 mg** Tablet | A4-9125 | Getz Pharma Nigeria Limited | active | 24 May 2028 |
| Candesartan 8 mg Tablets Tablet | B4-5705 | Korlyns Pharmaceuticals Ltd | active | 15 Dec 2026 |
| Candesartan 16 mg Tablets Tablet | B4-5707 | Korlyns Pharmaceuticals Ltd | active | 15 Dec 2026 |
Candesartan Cilexetil — NAFDAC Registration Details
NAFDAC (Nigeria) has 4 registered products containing Candesartan Cilexetil, of which 4 are currently active. Data is sourced directly from the official NAFDAC drug register and refreshed daily.
Track Candesartan Cilexetil registration expiry dates, monitor competitor approvals, and receive alerts when registration status changes. Create a free account to set up portfolio monitoring.